You are subscribed to the FormularyWatch.

Formulary

eNewsletter Subscribe

December 24, 2014

Web Version  | Share with a colleague

Facebook Like Twitter Tweet

Today's Headlines

Class action suit latest problem with Sovaldi

The Southeastern Pennsylvania Transportation Authority (SEPTA) recently filed a class action suit in federal court against Gilead Sciences, Inc. over the high cost of its hepatitis C drug, Sovaldi.
» More on the alleged complaint

Link between Rx drugs and teen drug abuse: Study

One medical center is urging parents to seek non-medical solutions for their children’s anxiety or insomnia, after a recent study found that teens prescribed anti-anxiety or sleep medications are up to 12 times more likely to abuse prescription drugs than those who had never been prescribed them.
» Study details

Continuing Education

MTM essentials for smoking cessation

This month's CE activity is part of a year-long CPE series, Medication Therapy Management Considerations for Adult Patients with Cardiovascular Disease. From February 2014 through January 2015, pharmacists can earn up to 24 hours of CPE credit with 12 monthly knowledge-based activities from the University of Connecticut School of Pharmacy and Drug Topics.

The goal of this month's activity is to assist pharmacists in providing smoking cessation services for patients interested in quitting smoking..

To read and print the article with TEST QUESTIONS, click here. To proceed to the online exams and earn up to 2 CPE credits, click here to log in with the session code 14DT13-KCE28.


Announcement: Our CE activities have moved to a new learning management system to better serve you. The login to the Online CE Center is https://web2.uconn.edu/pharmacyce/login.php. All current user registration information has been uploaded for your convenience. Current users do not need to register. To review your registration page to ensure the data is up to date or to register, go to https://web2.uconn.edu/pharmacyce/program_register.php. For a full list of courses, go to http://pharmacy.uconn.edu/academics/ce/drug-topics-and-uconn-ce/

EDITOR'S PICK

Novel new drugs approved in 2014

A total of 35 novel new drugs were approved this year, up from the total of 27 approved in 2013. Seven of them are breakthrough new molecular entities (NMEs) and 15 orphan NMEs. » Details

 

RELATED ARTICLES

FDA approves Viekira Pak to treat hepatitis C

Naloxone price increases may threaten public safety

RESOURCES

Latest Clinical News

Powered by Modern Medicine Advanstar Medical Communications Group